CO5360641A1 - Compuestos quimicos - Google Patents

Compuestos quimicos

Info

Publication number
CO5360641A1
CO5360641A1 CO00097282A CO00097282A CO5360641A1 CO 5360641 A1 CO5360641 A1 CO 5360641A1 CO 00097282 A CO00097282 A CO 00097282A CO 00097282 A CO00097282 A CO 00097282A CO 5360641 A1 CO5360641 A1 CO 5360641A1
Authority
CO
Colombia
Prior art keywords
chemical compounds
compounds
methods
farnesylation
fptase
Prior art date
Application number
CO00097282A
Other languages
English (en)
Inventor
Francis Thomas Boyle
Michael James Wardelworth
Matusiak Zbignieew
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CO5360641A1 publication Critical patent/CO5360641A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos de fórmula I que inhiben la farnesilación de productos de genes a través de inhibición de la enzima transferasa de proteína farnesil (FPtase) La invención también se relaciona con métodos de fabricar los compuestos, composiciones farmacéuticas y métodos de tratamiento de enfermedades, especialmente cáncer, las cuales están mediadas a través de farnesilación.
CO00097282A 1999-12-22 2000-12-22 Compuestos quimicos CO5360641A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9930318.2A GB9930318D0 (en) 1999-12-22 1999-12-22 Novel compounds

Publications (1)

Publication Number Publication Date
CO5360641A1 true CO5360641A1 (es) 2004-01-30

Family

ID=10866834

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00097282A CO5360641A1 (es) 1999-12-22 2000-12-22 Compuestos quimicos

Country Status (27)

Country Link
US (1) US7101897B2 (es)
EP (1) EP1255733B1 (es)
JP (1) JP3742593B2 (es)
KR (1) KR20020063251A (es)
CN (2) CN1229344C (es)
AR (1) AR029460A1 (es)
AT (1) ATE316074T1 (es)
AU (1) AU776003B2 (es)
BR (1) BR0016669A (es)
CA (1) CA2387579A1 (es)
CO (1) CO5360641A1 (es)
CZ (1) CZ20022125A3 (es)
DE (1) DE60025650D1 (es)
EE (1) EE200200206A (es)
GB (1) GB9930318D0 (es)
HU (1) HUP0204135A3 (es)
IL (1) IL149871A0 (es)
IS (1) IS6358A (es)
MX (1) MXPA02005981A (es)
MY (1) MY133606A (es)
NO (1) NO20022924L (es)
NZ (1) NZ518341A (es)
PL (1) PL355887A1 (es)
RU (1) RU2259997C2 (es)
SK (1) SK8642002A3 (es)
WO (1) WO2001046137A1 (es)
ZA (1) ZA200202694B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117864A1 (en) * 2004-05-28 2005-12-15 Astrazeneca Ab Combination product comprising anastrozole and a dual prenyl transferase inhibitor
CN101072783A (zh) * 2004-10-08 2007-11-14 寿制药株式会社 膦酸衍生物以及与血液高磷酸相关的疾病的治疗药
WO2007092285A2 (en) * 2006-02-02 2007-08-16 Link Medicine Corporation Treatment of synucleinopathies
WO2009151683A2 (en) 2008-03-12 2009-12-17 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
BRPI0920927A2 (pt) 2008-11-13 2019-09-24 Link Medicine Corp derivados de azaquinolinona e usos dos mesmos
CN102448458B (zh) 2009-03-18 2015-07-22 小利兰·斯坦福大学理事会 治疗黄病毒科病毒感染的方法和组合物
WO2011088126A2 (en) * 2010-01-13 2011-07-21 Eiger Biopharmaceuticals, Inc. Treatment of viral infection with prenyltransferase inhibitors

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60233076A (ja) 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
EP0182213B1 (en) 1984-11-08 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Carbapenem compounds and production thereof
KR880006244A (ko) 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
GB8921635D0 (en) 1989-09-25 1989-11-08 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives
CA2036163C (en) 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
CA2036941A1 (en) 1990-02-23 1991-08-24 Isao Kawamoto Carbapenem derivatives having antibiotic activity, their preparation and their use
GB9107363D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
US6083917A (en) 1990-04-18 2000-07-04 Board Of Regents, The University Of Texas System Methods and compositions for the identification, characterization and inhibition of farnesyltransferase
US5185248A (en) 1990-05-08 1993-02-09 E. R. Squibb & Sons, Inc. Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation
JPH0578360A (ja) 1991-01-31 1993-03-30 Banyu Pharmaceut Co Ltd ２−［２−（スルフアモイルアルキル）ピロリジニルチオカルバペネム誘導体
GB9107342D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107341D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
IL102093A (en) 1991-06-04 1996-12-05 Sankyo Co History of 1-methylcarbamene, processes for their preparation and pharmaceutical preparations containing them
JPH04368386A (ja) 1991-06-18 1992-12-21 Sankyo Co Ltd １−メチルカルバペネム−３−カルボン酸の製造法
US5360798A (en) 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
ES2075630T3 (es) 1991-10-11 1995-10-01 Squibb & Sons Inc Uso de inhibidores de la proteina-farnesil transferasa para la preparacion de un medicamento para bloquear la transformacion neoplastica de celulas inducidas por oncogenes ras.
JPH05239058A (ja) 1991-12-17 1993-09-17 Fujisawa Pharmaceut Co Ltd ３−ピロリジニルチオ−１−アザビシクロ［３．２．０ヘプト−２−エン−２−カルボン酸化合物
GB9202298D0 (en) 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
FI103046B (fi) 1992-03-11 1999-04-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrrolidinyylitiokarbapeneemij ohdannaisten valmistamiseksi
GB9304156D0 (en) 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2091309A1 (en) 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
EP0636133A1 (en) 1992-04-13 1995-02-01 Fujisawa Pharmaceutical Co., Ltd. Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
CA2099818A1 (en) 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
EP0581501B1 (en) 1992-07-21 1998-09-09 Zeneca Limited Antibiotic carbapenem compounds
EP0581502B1 (en) 1992-07-21 1998-10-21 Zeneca Limited Antibiotic carbapenem compounds
EP0590885B1 (en) 1992-09-28 2000-03-15 Zeneca Limited Antibiotic carbapenem compounds
CA2106330A1 (en) 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
CA2118985A1 (en) 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
US5736539A (en) 1993-06-18 1998-04-07 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP2534823B2 (ja) 1993-07-07 1996-09-18 日本電気株式会社 印刷装置
JPH09504277A (ja) 1993-09-30 1997-04-28 メルク エンド カンパニー インコーポレーテッド ファルネシル−タンパク質トランスフェラーゼの阻害剤
US5468733A (en) 1993-09-30 1995-11-21 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2155448A1 (en) 1994-08-11 1996-02-12 Katerina Leftheris Inhibitors of farnesyl protein transferase
US5571835A (en) 1994-09-29 1996-11-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2216564A1 (en) 1995-03-29 1996-10-03 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
BR9609744A (pt) 1995-07-31 1999-03-02 Shionogi & Co Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
JPH1050029A (ja) 1996-05-28 1998-02-20 Nobuyuki Higuchi 情報記憶装置
JP2001500118A (ja) * 1996-08-17 2001-01-09 ゼネカ・リミテッド ファルネシルタンパク質トランスフェラーゼ阻害剤としての３―メルカプトピロリジン
JP2001509156A (ja) 1997-01-29 2001-07-10 ゼネカ・リミテッド ファルネシルプロテイントランスフェラーゼの阻害剤
AU7371998A (en) 1997-05-07 1998-11-27 University Of Pittsburgh Inhibitors of protein isoprenyl transferases
JP2002503650A (ja) 1998-02-10 2002-02-05 アストラゼネカ ユーケー リミテッド ファルネシルトランスフェラーゼ阻害剤

Also Published As

Publication number Publication date
RU2002119405A (ru) 2004-01-10
AR029460A1 (es) 2003-07-02
HUP0204135A3 (en) 2005-03-29
NO20022924D0 (no) 2002-06-18
EP1255733B1 (en) 2006-01-18
JP2003518091A (ja) 2003-06-03
CA2387579A1 (en) 2001-06-28
SK8642002A3 (en) 2002-12-03
EE200200206A (et) 2003-04-15
CN1229344C (zh) 2005-11-30
MY133606A (en) 2007-11-30
KR20020063251A (ko) 2002-08-01
EP1255733A1 (en) 2002-11-13
US7101897B2 (en) 2006-09-05
NZ518341A (en) 2004-01-30
AU2201301A (en) 2001-07-03
CN1680313A (zh) 2005-10-12
BR0016669A (pt) 2002-10-08
ATE316074T1 (de) 2006-02-15
US20030083348A1 (en) 2003-05-01
WO2001046137A1 (en) 2001-06-28
GB9930318D0 (en) 2000-02-09
CN1411442A (zh) 2003-04-16
AU776003B2 (en) 2004-08-19
ZA200202694B (en) 2003-12-31
JP3742593B2 (ja) 2006-02-08
MXPA02005981A (es) 2005-07-01
RU2259997C2 (ru) 2005-09-10
IS6358A (is) 2002-04-23
DE60025650D1 (de) 2006-04-06
PL355887A1 (en) 2004-05-31
IL149871A0 (en) 2002-11-10
NO20022924L (no) 2002-06-18
CZ20022125A3 (cs) 2002-09-11
HUP0204135A2 (hu) 2003-03-28

Similar Documents

Publication Publication Date Title
ATE232873T1 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
BR9908280A (pt) Inibidores de enzimas de fosfolipase
AU2001233726A1 (en) Farnesyl protein transferase inhibitors for treating breast cancer
ES2194501T3 (es) Derivados de amidinas, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
BR0104424A (pt) Composições de pirazol úteis como inibidores de erk
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
BRPI0418031A (pt) inibidores de quinase fosfonato-substituìdos
BR9712831A (pt) Inibidores tricìclicos de farnesil proteìna transferase
PT966465E (pt) Inibidores do enzima imfdh
LU91145I9 (es)
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
WO2003106381A3 (en) ADAM 10 HUMAN INHIBITORS
ATE323490T1 (de) Farnesyl-protein-transferasehemmer zur behandlung der entzündlichen darmerkrankung
ATE299854T1 (de) Chinonverbindungen zur behandlung von krankheiten
CO5360641A1 (es) Compuestos quimicos
DK1105114T3 (da) Nimesulidholdige topiske farmaceutiske sammensætninger
BR0309386A (pt) Inibidores de metaloproteinases de triaril-óxi-arilóxi-pirimidina-2,4,6-triona
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
ES2182035T3 (es) Derivados del bisarilciclobuteno como inhibidores de ciclooxigenasa.
UY26501A1 (es) Derivados de piperazina sustituidos, su preparación y su empleo como medicamentos
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
BR9713744A (pt) Inibidores de cicloalquia da proteìna farnesil transferase
BR0016667A (pt) Composto, e, composição farmacêutica

Legal Events

Date Code Title Description
FC Application refused